Pulmonary Pathophysiology and Inflammatory Response in Patients Treated With Ecmo for Severe Respiratory Failure

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01468142

Enrollment

Registered

2011-11-09

Start date

2012-02-29

Completion date

2016-12-31

Last updated

2016-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress Syndrome, Adult, Respiratory Distress Syndrome, Child

Brief summary

The purpose of this study is the observation of the course of * the mechanics of the respiratory system * the endexpiratory lung volume * and the inflammatory response in patients undergoing treatment with extracorporeal life support (ECLS) due to severe refractory respiratory failure at our department.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

3 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients accepted for extracorporeal life support at our department due to the most severe forms of ARDS/respiratory failure not responding to conventional therapy.

Exclusion criteria

* malignant disease with a poor prognosis * massive intracranial bleeding

Design outcomes

Primary

Measure	Time frame
Course of inflammatory parameters and lung function	end of treatment

Countries

Sweden

Outcome results